Executive record

Richard S. Lindahl

Richard S. Lindahl signed Emergent BioSolutions Inc.'s 10-K as Executive Vice President, Chief Financial Officer (Principal Financial and Accounting Officer), filed February 27, 2026.

1 verified record · 1 company

Career line from the records

1

Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.

  1. 2026-02-2710-K signatureEmergent BioSolutions Inc.

    Signed the annual report as Executive Vice President, Chief Financial Officer (Principal Financial and Accounting Officer)

    10-K filed February 27, 2026 · sec.gov

Companies

1

Emergent BioSolutions Inc.EBS

Pharmaceutical Preparations

This page lists only verified filing records that name Richard S. Lindahl, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.